Hims & Hers Health, Inc.
General ticker "HIMS" information:
- Sector: Health Care
- Industry: Medical - Equipment & Services
- Capitalization: $7.4B (TTM average)
Hims & Hers Health, Inc. follows the US Stock Market performance with the rate: 17.8%.
Estimated limits based on current volatility of 4.6%: low 27.43$, high 30.07$
Factors to consider:
- Total employees count: 2442 (+49.2%) as of 2025
- US accounted for 94.3% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Rapid growth execution, Sustain profitability, Customer retention, Market competition, Regulatory and compliance
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [17.10$, 36.63$]
- 2026-12-31 to 2027-12-31 estimated range: [13.53$, 29.33$]
Financial Metrics affecting the HIMS estimates:
- Positive: with PPE of 68.1 at the end of fiscal year the price was neutral
- Positive: 0.56 < Operating profit margin, % of 4.50
- Positive: 5.14 < Return on assets ratio (scaled to [-100,100]) of 5.62
- Negative: Industry earnings per price (median), % of -0.62 <= 0
- Positive: 2.37 < Operating cash flow per share per price, % of 3.91
- Negative: 0 < Industry inventory ratio change (median), % of 0
- Negative: 12.78 < Shareholder equity ratio, % of 25.10 <= 25.20
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0.25 <= 0.41
Short-term HIMS quotes
Long-term HIMS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $872.00MM | $1,476.51MM | $2,347.64MM |
| Operating Expenses | $901.45MM | $1,414.61MM | $2,242.02MM |
| Operating Income | $-29.45MM | $61.90MM | $105.61MM |
| Non-Operating Income | $7.88MM | $9.81MM | $18.31MM |
| R&D Expense | $48.23MM | $78.82MM | $149.30MM |
| Income(Loss) | $-21.57MM | $71.71MM | $123.92MM |
| Taxes | $1.98MM | $-54.33MM | $-4.44MM |
| Net Income(Loss)* | $-23.55MM | $126.04MM | $128.37MM |
| Stockholders Equity | $344.03MM | $476.72MM | $540.93MM |
| Inventory | $22.46MM | $64.43MM | $115.73MM |
| Assets | $441.19MM | $707.54MM | $2,154.70MM |
| Operating Cash Flow | $73.48MM | $251.08MM | $300.01MM |
| Capital expenditure | $26.49MM | $52.75MM | $226.04MM |
| Investing Cash Flow | $-12.11MM | $-19.05MM | $-1,024.96MM |
| Financing Cash Flow | $-11.47MM | $-107.84MM | $729.62MM |
| Earnings Per Share** | $-0.11 | $0.58 | $0.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.